This Pre-Solicitation opportunity from Department Of Health And Human Services was posted on May 14, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

BIO RAD LABORATORIES INC. – LIQUICHEK TUMOR REGEANTS

Closed

26-005107Federal

Submission Closed05/24/2026, 06:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325413

New

Federal

Olink Explore HT Reagent Kit Supplier

National Institutes Of Health Olao

POSTED

DEADLINE

Solicitation # 36C25727Q0016

The Department of Veterans Affairs, Network Contracting Office 17, is issuing a Sources Sought Notice to identify capable providers for a fully automated gel electrophoresis instrument. The equipment will be used by the Pathology and Laboratory Medicine Service at the Audie L. Murphy Memorial VA Hospital in San Antonio, Texas, to perform serum and urine electrophoresis, immunofixation, and immunotyping to identify monoclonal and polyclonal gammopathies. This notice is for planning purposes only and does not constitute a formal solicitation or an obligation to award a contract. Interested parties must submit their company name, point of contact, SAM UEI or DUNS number, socio-economic status, and a capability statement to Jose Campa by September 22, 2026, at 10:00 AM CST. The government will use the responses to determine if there are sufficient small business concerns capable of fulfilling the requirement.

257-NETWORK Contract Office 17 (36C257)

POSTED

DEADLINE

TEST KIT, CHLAMYDIA TRA

Solicitation # SPE2DS-26-T-423P

Solicitation SPE2DS-26-T-423P, issued by the DLA Troop Support Medical Supply Chain, is a request for quotes for one test kit for the detection of Chlamydia trachomatis, identified by NSN 6550-01-725-3600. The kit is designed for in vitro diagnostic use to perform qualitative direct immunofluorescence tests on human urogenital and ophthalmic specimens, as well as for confirming Chlamydia in cell culture. Each kit must provide materials for 50 tests and include two positive control slides, mounting fluid, Chlamydia test reagent, and instructions for use. The required delivery date is September 14, 2026, with the place of performance and delivery located in San Antonio, Texas. The procurement falls under NAICS code 325413 and is subject to destination inspection and acceptance. Packaging must adhere to commercial standards, MIL-STD-2073-1E, and RP001, while marking must comply with Medical Marking Standard No. 1. The contract incorporates various FAR and DFARS clauses, including the Buy American and Balance of Payments Program and the Hazard Communication Standard for hazardous materials. Payment and invoicing are to be processed electronically through the Wide Area WorkFlow system. Quotes must be submitted via the DIBBS portal by September 16, 2026, and the award may be processed through an automated system, with a price evaluation preference applied to HUBZone concerns.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

TEST KIT, CORONAVIRUS D

Solicitation # SPE2DS-26-T-421Y

Solicitation SPE2DS-26-T-421Y is a fixed-price request for quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of one case of Abbott BinaxNOW COVID-19 Antigen self-test kits for over-the-counter, at-home use. The kits, identified by NSN 6550-01-716-1573, must be delivered to the USNS John L. Canley T-ESB-6 in San Diego, California. Each case contains 12 kits with two tests per kit. The items are subject to a non-extendable shelf life of 12 months, and no more than one month may have elapsed from the date of manufacture to the date of delivery to the government. The contractor must adhere to strict storage and marking requirements, maintaining the kits between 2-30 degrees Celsius and labeling all materials according to Medical Marking Standard No. 1. Packaging must be commercial, utilizing sealed unit containers and suitable exterior shipping containers in accordance with RP001 DLA Packaging Requirements. All labels must include the contract or lot number and the date of manufacture and expiration. Quotes must be submitted via the DIBBS system by September 16, 2026, and the award will be automated. Payment and receiving reports are to be processed electronically through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Blood Bank Reagents and Consumables Supply

POSTED

DEADLINE

Urine Drug Screening and Confirmation Laboratory Services

Residential Reentry - Co

POSTED

DEADLINE

Intent to Sole Source- Automated Blood Bank Instrumentation

Solicitation # PZIBABPA

The Air Force Life Cycle Management Center intends to award a sole-source, firm-fixed-price Blanket Purchase Agreement to QuidelOrtho Sales Company, LLC. This contract provides automated blood bank instrumentation, reagents, consumables, and associated support for the 88th Medical Group Laboratory Flight at Wright-Patterson Air Force Base. The requirement specifies a fully automated, continuous-access system that integrates with laboratory information systems, including MHS Genesis, to ensure uninterrupted blood bank operations. The decision to sole source follows extensive market research and a Sources Sought notice, which determined that QuidelOrtho is the only available source capable of meeting the minimum technical requirements. These requirements include specific methodology, FDA-approved reagent kits, and a single-platform solution for blood bank testing. The procurement falls under NAICS code 325413. Interested parties wishing to challenge the sole-source intent must submit a detailed capability statement to the designated points of contact by September 22, 2026.

POSTED

DEADLINE

Supplier of I-STAT PT Plus Control Reagent Level 2

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CONTROL, BLOOD CHEMISTR

Solicitation # SPE2DS-26-T-415T

This contract is for the procurement of one box of PT Plus Control Reagent Level 2, used for coagulation testing with the i-STAT PT Plus cartridge on the i-STAT 1 Government Field Kit analyzer. The item is issued in boxes containing ten 1.0ml units and is identified by NSN 6550-01-725-6872. Delivery is required within 20 days after the order is placed. The reagent has a non-extendable shelf life of 12 months, and no more than one month may elapse between the date of manufacture and delivery to the government. Storage requires refrigeration between 2 to 8 degrees Celsius, and the product must not be frozen. All supplies must adhere to DLA packaging and medical marking standards, including specific labeling for manufacture and expiration dates, contract numbers, and lot numbers.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CONTROL, BLOOD CHEMISTR

Solicitation # SPE2DS-26-T-415M

This contract is for the procurement of one box of i-STAT PT Plus Control Reagent Level 1, used for coagulation testing on the i-STAT 1 Government Field Kit blood gas analyzer. Each box contains ten 1.0 ml units. The item is subject to a non-extendable shelf life of 12 months, with a requirement that no more than one month passes between the date of manufacture and the date of delivery to the government. Proper refrigeration is required for storage between 2 to 8 degrees Celsius. The supplier must adhere to DLA packaging and medical marking standards, ensuring each unit is sealed and protected in commercial shipping containers. All labels must clearly state the contract number, lot number, and dates of manufacture and expiration. Delivery is required within 20 days after the order is placed. Bidders are required to specify the source and part number being supplied.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Solicitation # SPE2DS-26-T-409W

This contract is for the procurement of one benzene chip designed for use with a CMS analyzer. The chip features ten measurement capillaries filled with a substance-specific reagent system, providing a measuring range of 0.5 to 10.0 ppm and a total capacity of ten tests. The item is identified by NSN 6550-01-530-9389 and must be delivered within 20 days after the order is placed. The product is subject to a non-extendable shelf life of 24 months, with a requirement that no more than three months elapse between the date of manufacture and the date of delivery to the government. Packaging must meet commercial standards and be secured in sealed unit containers to prevent damage. All labeling and marking must comply with Medical Marking Standard No. 1, including the date of manufacture, expiration or retest date, and the contract or lot number.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

TEST KIT, BACTERIA DETE

Solicitation # SPE2DS-26-T-410L

This solicitation, issued by the Department of Defense Medical Supply Chain, is for the procurement of four packages of Pathogel bacteria determination test kits under solicitation number SPE2DS-26-T-410L. These single-use, self-contained kits utilize a selective medium and special gelling agent to detect coliform, E. coli, and hydrogen sulfide producing enterobacteriaceae, such as Salmonella and Citrobacter, in food, beverages, and water. The kits provide results within 28 hours and are capable of detecting 1CFU per 100ml in water and 1CFU per 3ml in juice. Each package contains 25 units. The contract specifies a non-extendable shelf life of six months, requiring that no more than one month has elapsed from the date of manufacture to the date of delivery. Items must be stored and shipped between 15 and 25 degrees Celsius and must adhere to Medical Marking Standard No. 1 and DLA packaging requirements. Delivery is required within 20 days after receipt of the order for the place of performance at Fort Riley. Bidders are required to specify the source and part number being supplied for NSN 6550-01-723-3649.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

4 days ago

DEADLINE

in 2 days

AI Contract Overview

The National Institutes of Health Clinical Center in Bethesda, Maryland intends to award a sole source firm-fixed-price contract to Bio-Rad Laboratories for the procurement of Liquichek Tumor Reagents, which are critical testing controls for cardiac, cancer, and infectious disease markers used in the Department of Laboratory Medicine’s Immunoassay laboratory. These reagents ensure consistent, high-quality results across 35 active research and clinical protocols, many of which span multiple years and require uninterrupted analytical stability. Bio-Rad is the exclusive manufacturer of these reagents, and substitution with alternative products would necessitate extensive revalidation and regulatory approval, potentially delaying patient care and compromising diagnostic accuracy. This acquisition is being conducted under FAR 13.106-1(b)(1), which permits sole source procurement when only one supplier can meet the government’s requirements. Although this notice is not a formal solicitation and does not invite competitive quotations, interested parties may submit a capability statement demonstrating their ability to supply the reagents, including company details, technical capability, proof of OEM authorization, and relevant past performance. Submissions must reference POTS 26-005107 and be received electronically by May 24, 2026, at 8:00 AM EST to the designated point of contact at the NIH Office of Acquisitions and Logistics Management. The government retains full discretion in deciding not to compete the requirement, and the contract will be performed at the NIH Clinical Center in Bethesda, Maryland.

General Info

NIH awards sole-source contract to Bio-Rad for critical Liquichek Tumor Reagents supply.

Agency

Department Of Health And Human Services → National Institutes Of Health OlaoView Agency

NAICS

325413 - In-Vitro Diagnostic Substance ManufacturingView NAICS

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed

PostedMay 14

Presolicitation

Response DeadlineMay 24

Deadline has passed

Submission Closed

05/24/2026, 06:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao

Contacts1 person available

OfficeBETHESDA, MD, 20892, USA

Organization / Agency

Department Of Health And Human Services → National Institutes Of Health Olao

View Agency Profile

Office AddressBETHESDA, MD, 20892, USA

Contacts

Gregory Noland

contact@example.gov

+1 (555) 000-0000

Full Description

Place of Performance:
National Institutes of Health
Clinical Center
Bethesda, MD 20892

POTS: 26-005107

Description

This notice is issued for informational purposes only and does not constitute a request for quotations. A solicitation will not be issued, and quotations will not be requested.

The National Institutes of Health (NIH), Clinical Center, intends to award a sole source firm-fixed-price contract to Bio-Rad Laboratories for the procurement of Liquichek Tumor Regeants.

The requirement consists of testing controls for cardiac, cancer and infectious disease markers for Liquichek Tumor Regeants, which provide consistent, high-quality results for clinical center patients within the Department of Laboratory Medicine (DLM) Immunoassay laboratory.

Background

The Department of Laboratory Medicine (DLM) Immunoassay laboratory currently provides services for 35 protocols across several Institutes, and they all require highly accurate and rapid results. In addition, some research protocols extend over several years, it is very important for laboratory values to remain consistent over time through the same testing methodologies and similar instrumentation.

Rationale:

Bio-Rad Laboratories is the sole manufacturer of Liquichek Tumor Regeants. Substitution is not permissible without revalidation and regulatory approval, which could delay treatment and pose risks to patient care

Authority

This acquisition is being conducted in accordance with:

FAR 13.106-1(b)(1) – Soliciting from a Single Source

Under this authority, the Contracting Officer may solicit from a single source when it is determined that only one source is reasonably available to meet the Government’s requirements.

Acquisitions conducted under FAR Part 13 – Simplified Acquisition Procedures are exempt from the competition requirements of FAR Part 6.

Responses

This is not a request for quotations. However, interested parties may submit a capability statement demonstrating their ability to meet the Government’s requirement.

Responses must include:

Company name and address
Technical capability
Proof of OEM authorization
Relevant past performance

The Government will evaluate capability statements received in response to this notice. The determination not to compete this requirement is solely within the discretion of the Government.

Submission Instructions

Responses referencing POTS: 26-005107 must be submitted electronically no later than May 24, 2026, at 8:00 AM EST to:

Gregory Noland
Hospital and Laboratory Support Division

Office of Acquisitions and Logistics Management
National Institutes of Health

Email: gregory.noland@nih.gov